Abstract
OBJECTIVES. Every year about 38,000 elderly people with diabetes have a lower extremity amputation. Therapeutic shoes are prescribed by clinicians specializing in foot care to prevent foot ulcerations and amputations among at-risk patients with diabetes. Medicare ran a 3-year demonstration of a therapeutic-shoe benefit for beneficiaries with diabetes. Medicare added the benefit nationwide in May 1993. METHODS. This paper describes the benefit and its implementation in the demonstration based on demonstration records, a patient survey, and discussions with clinicians and shoe suppliers before and during the demonstration. RESULTS. During the demonstration, far fewer beneficiaries applied for the therapeutic shoes than were eligible for them. The paper discusses reasons for the low beneficiary application rate and the associated low participation rate among physicians treating patients with diabetes. CONCLUSIONS. The benefit is unlikely to be used any more in the national program than in the demonstration unless physicians are educated in the role therapeutic shoes can play in diabetic foot disease, they prescribe the shoes for their patients, and they increase their patients' awareness of the shoes' value.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Apelqvist J., Larsson J., Agardh C. D. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabet Complications. 1990 Jan-Mar;4(1):21–25. doi: 10.1016/0891-6632(90)90060-i. [DOI] [PubMed] [Google Scholar]
- Grunfeld C. Diabetic foot ulcers: etiology, treatment, and prevention. Adv Intern Med. 1992;37:103–132. [PubMed] [Google Scholar]
- Wooldridge J., Moreno L. Evaluation of the costs to Medicare of covering therapeutic shoes for diabetic patients. Diabetes Care. 1994 Jun;17(6):541–547. doi: 10.2337/diacare.17.6.541. [DOI] [PubMed] [Google Scholar]